<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Bryce Foster | Monahan Steenberg | Activity</title>
	<link>https://brycefoster.com/members/henelbow03/activity/</link>
	<atom:link href="https://brycefoster.com/members/henelbow03/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Monahan Steenberg.</description>
	<lastBuildDate>Sat, 25 Jul 2026 19:15:30 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">bb838c3e98fed938b01e6014d7230df3</guid>
				<title>Monahan Steenberg posted an update: Understanding the Solubility of Fentanyl Citrate: A Technical [&#133;]</title>
				<link>https://brycefoster.com/activity/p/1742851/</link>
				<pubDate>Mon, 01 Jun 2026 15:13:56 +0000</pubDate>

									<content:encoded><![CDATA[<p>Understanding the Solubility of Fentanyl Citrate: A Technical Overview for UK Pharmaceutical Contexts</p>
<p><em>Disclaimer: This post is planned for educational and professional details purposes only. Fentanyl citrate is a Class A controlled substance in the United Kingdom under the Misuse of Drugs Act 1971. Handling and formula should only be carried&hellip;</em><span class="activity-read-more" id="activity-read-more-1742851"><a href="https://brycefoster.com/activity/p/1742851/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">3c720ca03d7d2fa703cfb1054133852d</guid>
				<title>Monahan Steenberg posted an update: Understanding the Rise of Fentanyl Analogs in the United [&#133;]</title>
				<link>https://brycefoster.com/activity/p/1742489/</link>
				<pubDate>Mon, 01 Jun 2026 14:22:50 +0000</pubDate>

									<content:encoded><![CDATA[<p>Understanding the Rise of Fentanyl Analogs in the United Kingdom: A Comprehensive Guide</p>
<p>The landscape of substance misuse in the United Kingdom is going through a substantial and unsafe shift. While conventional narcotics like heroin have controlled the illegal opioid market for years, a more recent, more potent threat has emerged: artificial&hellip;<span class="activity-read-more" id="activity-read-more-1742489"><a href="https://brycefoster.com/activity/p/1742489/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">8de371e3075268fbfe6a30d284be7f3e</guid>
				<title>Monahan Steenberg posted an update: Understanding Fentanyl Test Kits in the UK: A Comprehensive [&#133;]</title>
				<link>https://brycefoster.com/activity/p/1742408/</link>
				<pubDate>Mon, 01 Jun 2026 14:13:53 +0000</pubDate>

									<content:encoded><![CDATA[<p>Understanding Fentanyl Test Kits in the UK: A Comprehensive Guide to Harm Reduction</p>
<p>The landscape of substance use in the United Kingdom is undergoing a substantial change. While the UK has historically seen lower rates of artificial opioid contamination compared to North America, recent information recommends an increasing existence of potent&hellip;<span class="activity-read-more" id="activity-read-more-1742408"><a href="https://brycefoster.com/activity/p/1742408/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a41463361c02677e8102f0517f5a2d6b</guid>
				<title>Monahan Steenberg became a registered member</title>
				<link>https://brycefoster.com/activity/p/1742344/</link>
				<pubDate>Mon, 01 Jun 2026 14:06:04 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>